These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Trisomy 21, after a half century]. Nau JY Rev Med Suisse; 2009 Feb; 5(190):380. PubMed ID: 19264068 [No Abstract] [Full Text] [Related]
8. [Antenatal screening for Down syndrome: a smattering of epidemiology]. Boulvain M; Billieux MH; Irion O Rev Med Suisse; 2008 Oct; 4(176):2276-8, 2280. PubMed ID: 19025178 [TBL] [Abstract][Full Text] [Related]
9. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency. Bestwick JP; Huttly WJ; Wald NJ J Med Screen; 2008; 15(4):204-6. PubMed ID: 19106261 [TBL] [Abstract][Full Text] [Related]
10. Lack of standardization in determining gestational age for prenatal screening. Koster MP; Van Leeuwen-Spruijt M; Wortelboer EJ; Stoutenbeek P; Elvers LH; Loeber JG; Visser GH; Schielen PC Ultrasound Obstet Gynecol; 2008 Oct; 32(5):607-11. PubMed ID: 18720453 [TBL] [Abstract][Full Text] [Related]
11. [Molecular biology usefulness for rapid diagnosis of Down's syndrome and common aneuploidies]. Fauret AL; Bilan F; Patri S; Couet D; Marechaud M; Pierre F; Gilbert-Dussardier B; Kitzis A Gynecol Obstet Fertil; 2009; 37(7-8):611-9. PubMed ID: 19574080 [TBL] [Abstract][Full Text] [Related]
13. Platyspondylic lethal skeletal dysplasia San Diego type (thanatophoric dysplasia type 1) associated with trisomy 21 presenting with nuchal translucency: a case report. Yamada T; Sawai H; Nishimura G; Numabe H; Cho K; Minakami H Prenat Diagn; 2009 Jul; 29(7):715-7. PubMed ID: 19340824 [No Abstract] [Full Text] [Related]
14. Combined test + inhibin A at week 13 in contingent sequential testing: an interesting alternative for first-trimester prenatal screening for Down syndrome. Ramos-Corpas DJ; Santiago JC Prenat Diagn; 2008 Sep; 28(9):833-8. PubMed ID: 18661488 [TBL] [Abstract][Full Text] [Related]
15. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467 [TBL] [Abstract][Full Text] [Related]
16. Evaluating nuchal translucency scans performed for trisomy screening in a district general hospital between July 1998 and January 2004. MacRae R; Ojutiku D; Duke-MacRae J; Usifo F; Ekong M J Obstet Gynaecol; 2008 Oct; 28(7):683-7. PubMed ID: 19065360 [TBL] [Abstract][Full Text] [Related]
18. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study. Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ; AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463 [TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of Pallister-Killian syndrome in two fetuses with increased nuchal translucency. Kim MH; Park SY; Kim MY; Lee BY; Lee MH; Ryu HM Prenat Diagn; 2008 May; 28(5):454-6. PubMed ID: 18438966 [No Abstract] [Full Text] [Related]
20. Increased fetal nuchal translucency as a sole clue in the prenatal diagnosis of a fetus with trisomy 13. Ki KD; Kim SR; Lee WI Fetal Diagn Ther; 2009; 26(1):54-6. PubMed ID: 19816033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]